Skip to main content
. 2024 Oct 12;16(10):e71341. doi: 10.7759/cureus.71341

Table 2. Adverse events during chemotherapy.

CTC-AE: Common terminology criteria for adverse events

%: percent

Adverse events (CTC-AE) All grade Grade1 Grade2 Grade 3
Diarrhea 11(30.6%) 8 (22.2%) 2 (5.6%) 1(2.8%)
Stomatitis 8 (22.2%) 8 (22.2%) 0
Nausea 14 (38.9%) 13 (36.1%) 1(2.8%) 0
Loss of appetite 14 (38.9%) 9 (25.0%) 5 (13.8%) 0
Fatigue 18 (50.0%) 14 (38.9%) 4 (11.1%) 0
Hand–foot syndrome 14 (38.9%) 10 (27.8%) 4 (11.1%) 0
Constipation 6 (16.6%) 3 (8.3%) 3 (8.3%) 0
Leukopenia 14 (38.9%) 10 (27.8%) 4 (11.1%) 0
Neutropenia 14 (38.9%) 7 (19.4%) 5 (13.8%) 2 (5.6%)
Anemia 14 (38.9%) 10 (27.8%) 2 (5.6%) 2 (5.6%)
Thrombocytopenia 12 (33.3%) 8 (22.2%) 2 (5.6%) 2 (5.6%)